Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Lesson of the month: Severe leukoencephalopathy by SARS-CoV-2

Leticia Sanz-Canalejas, María del Carmen Polidura-Arruga, Miguel Yus-Fuertes, Manuela Jorquera-Moya, Nieves Vidart-Simón, Juan Arrazola-García and Natividad Gómez-Ruiz
Download PDF
DOI: https://doi.org/10.7861/clinmed.2020-0940
Clin Med March 2021
Leticia Sanz-Canalejas
AClínico San Carlos University Hospital, Madrid, Spain;
Roles: senior radiology resident
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: leticia.sanzcanalejas48@gmail.com
María del Carmen Polidura-Arruga
BClínico San Carlos University Hospital, Madrid, Spain;
Roles: specialist registrar in neuroradiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Yus-Fuertes
BClínico San Carlos University Hospital, Madrid, Spain;
Roles: specialist registrar in neuroradiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Jorquera-Moya
BClínico San Carlos University Hospital, Madrid, Spain;
Roles: specialist registrar in neuroradiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nieves Vidart-Simón
CClínico San Carlos University Hospital, Madrid, Spain;
Roles: specialist registrar in intensive care medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Arrazola-García
DClínico San Carlos University Hospital, Madrid, Spain
Roles: professor and head of department of radiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natividad Gómez-Ruiz
BClínico San Carlos University Hospital, Madrid, Spain;
Roles: specialist registrar in neuroradiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

ABSTRACT

Neurological manifestations associated with SARS-CoV-2 infection as well as its pathogenesis are insufficiently explained. We present two cases of severe COVID-19 who required hospitalisation in the intensive care unit with persistently depressed mental status and severe leukoencephalopathy. We discuss the clinical and radiological findings and also propose the possible pathogenesis involved.

KEYWORDS:
  • COVID-19
  • coronavirus
  • leukoencephalopathy
  • brain
  • MRI

Introduction

The pathology of COVID-19, a new infectious disease, and its long-term damage are gradually being described. Scientific knowledge about the neurological involvement of the disease is currently not sufficient. We present two cases of COVID-19 and severe leukoencephalopathy in magnetic resonance imaging (MRI). We discuss the aetiology of these clinical and radiological findings, the neurotropism of SARS-CoV-2 and the pathogenesis of possible neurological infection.

Case report

Patient 1

A 54-year-old woman with morbid obesity and hypertension was admitted in our hospital with a working diagnosis of community-acquired pneumonia by SARS-CoV-2 that required intensive care unit (ICU) admission. She was managed with mechanical ventilation, intravenous sedation, neuromuscular blockers, prone positioning, vasopressor drugs and renal replacement therapy. She was treated with ritonavir–lopinavir, peginterferon alpha, hydroxychloroquine, ceftriaxone and clarithromycin. Her clinical status improved, although her mental status was persistently depressed despite the withdrawal of sedation. Magnetic resonance imaging (MRI) of the brain was performed and showed bilateral, symmetrical and confluent white matter hyperintense areas on both fast spin echo T2-weighted and fluid-attenuation inversion recovery (FLAIR), which were consistent with leukoencephalopathy (Fig 1). Lumbar puncture was not performed. Due to her clinical improvement she was moved to her reference hospital. Unfortunately, it has not been possible to perform a follow-up of any neurological long-term damage.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

1.5T magnetic resonance imaging of the brain. Faint bilateral and symmetrical, confluent frontoparietal lesions in centrum semiovale were noted on both fluid-attenuation inversion recovery T2-weighted imaging (a; arrows) and diffusion-weighted imaging (b; arrows) as hyperintense areas, with diffusion restriction on the apparent diffusion coefficient map (c; asterisks). d) No contrast enhancement fast spin echo T1-weighted imaging; a ghosting artifact is present (asterisk).

Patient 2

A 63-year-old man with chronic ischaemic heart disease was admitted to our hospital due to SARS-CoV-2 pneumonia. His condition worsened and required ICU admission. He was managed with the general measures of the critical patient with multiple organ failure and SARS-CoV-2 infection. His progression was favourable, so the sedation was withdrawn. Because his mental status was persistently depressed, MRI of the brain was performed and showed identical findings to those described in our previous case (Fig 2). Lumbar puncture was not performed. He was discharged and unfortunately it has not been possible to perform a follow-up of any neurological long-term damage.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

1.5T magnetic resonance imaging of the brain. Faint bilateral, symmetrical and confluent frontal lesions in centrum semiovale and corona radiata were noted both on fluid-attenuation inversion recovery T2-weighted imaging (a; arrows) and diffusion-weighted imaging (b; arrows) as hyperintense areas, with diffusion restriction on the apparent diffusion coefficient map (c; asterisks). d) No contrast enhancement fast spin echo T1-weighted imaging.

Discussion

From the neurological point of view, SARS-CoV-2 has been associated with ischaemic and haemorrhagic strokes, acute necrotising haemorrhagic encephalitis, stupor, coma and delirium in addition to headache, anosmia and ageusia.1 Up to 36% of patients with COVID-19 have neurological manifestations, being more frequent in patients with greater clinical severity.1 In critical patients with COVID-19, neurological symptoms usually involves several aetiological factors (such as sedation drugs, hypoxic and metabolic encephalopathy, encephalopathy induced by sepsis, and the potential neurological damage induced by the virus itself or by para-infectious mechanisms).1 Therefore, it is unlikely that a single isolated aetiological factor triggered the severe leukoencephalopathy of our patients.

It is well known that some betacoronaviruses are able to infect the brain of animals and humans.2,3 Neurons, and also glial and endothelial cells of the cerebral microcirculation are susceptible to infection by SARS-CoV-2 because they have angiotensin converting enzyme 2 receptors on their cell surface.1,4 Like any other pathogen with neurotropism, SARS-CoV-2 could infect the central nervous system using three well-known mechanisms. First, the blood–brain barrier altered by hypoxia and an inflammatory storm could favour the passage of the virus.5 The second mechanism is retrograde axonal infection, shown for SARS-CoV in a murine animal model through olfactory bulbs.6 Finally, the virus could access the brain inside infected immune cells (‘Trojan horse’ mechanism).7 SARS-CoV-2 has been detected in brain tissue by RT-PCR and electron microscopy and also in cerebrospinal fluid samples.7,8

Cerebrospinal fluid analysis and histopathology has shown lack of a strong inflammatory response associated to brain infection by SARS-CoV-2.6,8 COVID-19 lymphopenia is a marker of severity and an important prognostic factor.9 In autopsies of patients who died from SARS, there was a significant atrophy of the mucosa-associated lymphoid tissue (MALT), lymph nodes and spleen.10 Gu et al proposed that patients with the most severe forms of infections developed a rapidly progressive acquired cellular immunodeficiency and, in the late stages of infection, it would favour the spread of the virus in different organs with a low lymphocyte tissue infiltration.

Summary

We present two cases of severe leukoencephalopathy associated with SARS-CoV-2 in critically ill patients. Many questions remain to be resolved relating to COVID-19 and its long-term outcome, including potentially disabling neurological involvement. Therefore, scientific research, complementary tests (like MRI) and autopsies remain essential to improve morbidity and mortality associated with COVID-19.

Key points

  • COVID-19 often involves lungs, however, up to 36% of these patients have neurological manifestations, being more frequent in severe cases.

  • We describe and provide images of two cases of COVID-19 with severe leukoencephalopathy.

  • We discuss the neurotropism and the pathogenesis of possible neurological infection by SARS-CoV-2.

  • These cases showed the systemic and probable brain infection by SARS-CoV-2 and emphasises the importance of neurological evaluation and clinical follow-up of these patients.

  • © Royal College of Physicians 2021. All rights reserved.

References

  1. ↵
    1. Zhou Z
    , Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol 2020;267:2179–84.
    OpenUrlPubMed
  2. ↵
    1. Li YC
    , Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92:552–5.
    OpenUrlPubMed
  3. ↵
    1. Yashavantha Rao HC
    , Jayabaskaran C. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol 2020;92:786–90.
    OpenUrlCrossRef
  4. ↵
    1. Mankad K
    , Perry MD, Mirsky DM, Rossi A. COVID-19: A primer for Neuroradiologists. Neuroradiology 2020;62:647–8.
    OpenUrl
  5. ↵
    1. Zhengqian L
    , Taotao L, Ning Y, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med 2020;14:533–41.
    OpenUrl
  6. ↵
    1. Netland J
    , Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82:7264–75.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Paniz-Mondolfi A
    , Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 2020;92:699–702.
    OpenUrl
  8. ↵
    1. Moriguchi T
    , Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 2020;94:55–8.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Terpos E
    , Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol 2020;95: 834–47.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Gu J
    , Gong E, Zhang B, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med 2005;202:415–24.
    OpenUrlAbstract/FREE Full Text
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Lesson of the month: Severe leukoencephalopathy by SARS-CoV-2
Leticia Sanz-Canalejas, María del Carmen Polidura-Arruga, Miguel Yus-Fuertes, Manuela Jorquera-Moya, Nieves Vidart-Simón, Juan Arrazola-García, Natividad Gómez-Ruiz
Clinical Medicine Mar 2021, 21 (2) 155-157; DOI: 10.7861/clinmed.2020-0940

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Lesson of the month: Severe leukoencephalopathy by SARS-CoV-2
Leticia Sanz-Canalejas, María del Carmen Polidura-Arruga, Miguel Yus-Fuertes, Manuela Jorquera-Moya, Nieves Vidart-Simón, Juan Arrazola-García, Natividad Gómez-Ruiz
Clinical Medicine Mar 2021, 21 (2) 155-157; DOI: 10.7861/clinmed.2020-0940
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Introduction
    • Case report
    • Discussion
    • Summary
    • Key points
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Lessons of the month 1: Mesenteric ischaemia secondary to infective endocarditis
  • Lessons of the month 2: Olanzapine-induced hypothermia and hand oedema
  • Lessons of the month 2: A case of inappropriate drug–drug interaction in kidney transplant
Show more Lessons of the month

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians